Vaxxinova Intl. BV appoints Dymec Ceylon as exclusive distributor for Sri Lanka

Vaxxinova Technical Service Manager for Asia Ludio Gomes, DVM, exchanging the dealership agreement with Dymec Managing Director Hiran Nanayakkara. Joining them are Vaxxinova Regional Manager for Asia Kreangkrai Sangthongdang, and Dymec Director Dr. Priyantha Kospalawaththe

The Dymec team with Vaxxinova personnel

Vaxxinova International BV, a global leader in the manufacturing of animal vaccine products, has appointed Dymec Ceylon Ltd., a prominent player in the veterinary pharmaceutical industry in Sri Lanka, as its exclusive distributor for marketing and distributing vaccine products in the Sri Lankan market. 

The official announcement of this dealership took place during a product launch event held in Colombo, where it garnered the attention of senior veterinarians, farm owners, industry experts, as well as both Dymec and Vaxxinova teams.

Headquartered in the Netherlands, Vaxxinova International BV boasts a global presence, supported by their pioneering production, research and development, sales, and diagnostic facilities spanning 10 countries. These countries include Brazil, Chile, Germany, Italy, Japan, Jordan, Norway, the Netherlands, Thailand, and the USA. In a rapidly evolving world grappling with persistent disease challenges and emerging health risks in poultry, encompassing chickens and other poultry animals, Vaxxinova stands unwavering in its mission to provide state-of-the-art preventive solutions through world-class vaccines, ultimately reducing dependence on antibiotics. Vaxxinova offers a comprehensive array of both autogenous and licensed vaccines, complemented by advanced diagnostic services. The company’s dedication is primarily directed towards production animals, encompassing poultry, aquaculture, cattle, and swine.

Vaxxinova is a proud member of the EW Group, a family-owned German-based company with roots dating back to the 1950s in the production animal vaccine and diagnostics sector. The EW Group specialises in animal genetics, nutrition, and healthcare, operating across more than 100 countries.

In the process of selecting an exclusive distributor for the Sri Lankan market, Vaxxinova conducted a comprehensive market assessment and strategically chose Dymec Ceylon based on its robust presence and stellar reputation in the veterinary industry. Dymec Ceylon, a subsidiary of Dymec Ltd., is a rapidly growing veterinary pharmaceutical company in Sri Lanka. It already holds exclusive distributorship for veterinary medicines and feed additives from the globally renowned Interchemie Netherlands. 

Vaxxinova’s products, known globally for their excellence, are positioned to make a significant contribution to the local farming community and animal health in Sri Lanka. With Dymec Ceylon, a trusted leader in the industry, boasting an extensive customer network and a team of experts and professionals, this partnership is poised to foster the growth of sustainable and profitable livestock for farmers in the Sri Lankan veterinary industry.